These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15271952)

  • 21. [Vulvovaginal candidiasis: prevalence of different Candida species in the Liege region].
    Senterre JM; Carpentier M; Foidart JM
    Rev Med Liege; 2005 Nov; 60(11):882-4. PubMed ID: 16402534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
    Lian CH; Liu WD
    Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
    González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
    Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticandidal immunity and vaginitis: novel opportunities for immune intervention.
    Cassone A; De Bernardis F; Santoni G
    Infect Immun; 2007 Oct; 75(10):4675-86. PubMed ID: 17562759
    [No Abstract]   [Full Text] [Related]  

  • 25. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
    Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype distribution of Candida albicans strains associated with different conditions of vulvovaginal candidiasis, as revealed by microsatellite typing.
    Fan SR; Bai FY; Liao QP; Liu ZH; Li J; Liu XP
    Sex Transm Infect; 2008 Apr; 84(2):103-6. PubMed ID: 17971371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on etiologic agents of vaginitis].
    Shu M; Yu P; Yiao M
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):80-2. PubMed ID: 11938750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W; Brasch J; ; ; ;
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective immunity in experimental Candida vaginitis.
    Fidel PL; Sobel JD
    Res Immunol; 1998; 149(4-5):361-73; discussion 510-2. PubMed ID: 9720954
    [No Abstract]   [Full Text] [Related]  

  • 34. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
    Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
    Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorometric determination of acid proteinase activity in Candida albicans strains from diabetic patients with vulvovaginal candidiasis.
    Yildirim Z; Kilic N; Kalkanci A
    Mycoses; 2011 Sep; 54(5):e463-7. PubMed ID: 21039939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal candidiasis: review and role of local mucosal immunity.
    Fidel PL
    AIDS Patient Care STDS; 1998 May; 12(5):359-66. PubMed ID: 11361971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis of mucosal candidiasis (an ultrastructural study)].
    Bykov VL; Khokhlov SE
    Vestn Dermatol Venerol; 1987; (8):9-12. PubMed ID: 3318209
    [No Abstract]   [Full Text] [Related]  

  • 38. [The dynamics of the invasive growth of Candida albicans in the host's tissues].
    Bykov VL
    Vestn Dermatol Venerol; 1990; (4):25-8. PubMed ID: 2202166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
    Buscemi L; Arechavala A; Negroni R
    Rev Iberoam Micol; 2004 Dec; 21(4):177-81. PubMed ID: 15709796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.